Emergent BioSolutions (EBS) Total Liabilities (2010 - 2026)
Emergent BioSolutions (EBS) posted Total Liabilities of $775.4 million for Q2 2026, down 2.75% on a QoQ basis from $797.3 million in Q1 2026, and down 11.98% year-over-year from $880.9 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Total Liabilities (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Total Liabilities for 17 years, with the latest figure at $775.4 million in Q2 2026.
- On a quarterly basis, Total Liabilities fell 11.98% year-over-year to $775.4 million in Q2 2026; TTM through Jun 2026 was $775.4 million, a 11.98% decrease from a year earlier, with the FY2025 full-year figure at $796.0 million, down 12.23% from the prior year.
- Total Liabilities was $775.4 million for Q2 2026 at Emergent BioSolutions, down from $797.3 million in the prior quarter.
- The five-year high for Total Liabilities was $1.8 billion in Q4 2022, with the low at $775.4 million in Q2 2026.
- Average Total Liabilities over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities soared 44.98% in 2023, then tumbled 34.77% in 2024.
- Over 5 years, Total Liabilities stood at $1.8 billion in 2022, then tumbled by 34.0% to $1.2 billion in 2023, then decreased by 22.74% to $906.9 million in 2024, then retreated by 12.23% to $796.0 million in 2025, then slipped by 2.59% to $775.4 million in 2026.
- The last three Total Liabilities figures came in at $775.4 million (Q2 2026), $797.3 million (Q1 2026), and $796.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 23.74 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 115.64 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 65.32 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 69.15 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 4.00 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | 1.72 Bn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 775.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 775.40 Mn |
| Mar 31, 2026 | 797.30 Mn |
| Dec 31, 2025 | 796.00 Mn |
| Sep 30, 2025 | 878.50 Mn |
| Jun 30, 2025 | 880.90 Mn |
| Mar 31, 2025 | 873.40 Mn |
| Dec 31, 2024 | 906.90 Mn |
| Sep 30, 2024 | 969.40 Mn |
| Jun 30, 2024 | 1.13 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 1.17 Bn |
| Sep 30, 2023 | 1.20 Bn |
| Jun 30, 2023 | 1.22 Bn |
| Mar 31, 2023 | 1.75 Bn |
| Dec 31, 2022 | 1.78 Bn |
| Sep 30, 2022 | 1.46 Bn |
| Jun 30, 2022 | 1.22 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.35 Bn |
| Sep 30, 2021 | 1.34 Bn |
API Access
Emergent BioSolutions Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();